In the past six years, the market size of the Chinese healthcare industry has maintained a double-digit growth rate, and is expected to exceed RMB 330 billion yuan (USD $51.1 billion) in 2021, while the share of freeze-dried products is less than 1%. Therefore, the Chinese market can expect nearly RMB 100 billion yuan (USD $15.5 billion) of market consumption potential. In 2019, with leading freeze-dried health technology in the industry, Australian brand Vmores has launched freeze-dried probiotics, multivitamins, collagen, bird’s nest, and lactoferrin. Therefore, the world’s first freeze-dried health product brand Vmores also looks forward to leading the Chinese freeze-dried health products market. (Source: finance.ifeng)

Comments are closed.